Blinatumomab and better BCR::ABL1 inhibition begets better bone marrow transplant outcomes. Luskin MR, Leonard JT. Haematologica 2025 Jun 12. doi: 10.3324/haematol.2025.288068.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Luskin MR, Leonard JT. Blinatumomab and better BCR::ABL1 inhibition begets better bone marrow transplant outcomes. Haematologica 2025 Jun 12. doi: 10.3324/haematol.2025.288068.
PMID: 40501389